<Suppliers Price>

Quinolinium,2-[[[4-[bis(2-chloroethyl)amino]phenyl]imino]methyl]-1-methyl-, chloride (1:1)

Names

[ CAS No. ]:
25843-64-5

[ Name ]:
Quinolinium,2-[[[4-[bis(2-chloroethyl)amino]phenyl]imino]methyl]-1-methyl-, chloride (1:1)

[Synonym ]:
Zimet 3106
Imet 3106

Chemical & Physical Properties

[ Molecular Formula ]:
C21H22Cl3N3

[ Molecular Weight ]:
422.77800

[ Exact Mass ]:
421.08800

[ PSA ]:
19.48000

[ LogP ]:
1.70290

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VC3537000
CHEMICAL NAME :
Quinolinium, 2-(N-(p-(bis(2-chloroethyl)amino)phenyl)formimidoyl)- 1-methyl-, chloride
CAS REGISTRY NUMBER :
25843-64-5
LAST UPDATED :
198909
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C21-H22-Cl2-N3.Cl
MOLECULAR WEIGHT :
422.81
WISWESSER LINE NOTATION :
T66 BKJ B1 C1UMR DN2G2G &G

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
125 mg/kg
SEX/DURATION :
female 7-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
REFERENCE :
ZPPLBF Zentralblatt fuer Pharmazie, Pharmakotherapie und Laboratoriums-diagnostik. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, 102 Berlin, Ger. Dem. Rep.) V.109- 1970- Volume(issue)/page/year: 110,1067,1971
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
188 mg/kg
SEX/DURATION :
female 7-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
REFERENCE :
ZPPLBF Zentralblatt fuer Pharmazie, Pharmakotherapie und Laboratoriums-diagnostik. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, 102 Berlin, Ger. Dem. Rep.) V.109- 1970- Volume(issue)/page/year: 110,1067,1971
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
125 mg/kg
SEX/DURATION :
female 7-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 22,122,1972